Skip to main content

Nancy E. Denyes

General Counsel

aTYR PHARMA INC (ATYR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nancy E. Denyes

Nancy E. Denyes is recorded as General Counsel at aTYR PHARMA INC (ATYR). The proxy statement of aTYR PHARMA INC reports total compensation of $1,284,841 for Nancy E. Denyes in fiscal 2025, including a base salary of $451,570. Disclosed compensation is on record for 7 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at aTYR PHARMA INC

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 aTYR PHARMA INC (ATYR) $451,570 $1,284,841
2024 aTYR PHARMA INC (ATYR) $410,517 $729,305
2023 aTYR PHARMA INC (ATYR) $396,635 $651,283
2022 aTYR PHARMA INC (ATYR) $396,635 $857,528
2021 aTYR PHARMA INC (ATYR) $360,577 $891,288
2020 aTYR PHARMA INC (ATYR) $350,075 $625,257
2019 aTYR PHARMA INC (ATYR) $335,000 $449,263

Recent activity

No call appearances or filed executive changes recorded yet.